Macquarie cuts XPeng stock rating on volume growth concerns By Investing.com

Macquarie downgraded XPeng to Neutral from Outperform and cut its price target to $19 (from $24), trimming fiscal-2026 unit volume by 7% and widening the 2026 loss-per-share estimate to -1.28 yuan (from -0.45). XPeng reported solid Q4 2025 revenue of RMB22.25bn (+38% YoY) and a 21.3% gross margin, while Morgan Stanley kept Overweight with a $34 target and the company is targeting ~20% group gross margin in Q1 2026 and mid- to high-teens for the full year. Strategic positives include VLA 2.0 autonomous system praise, a potential Stellantis partnership and a Hong Kong in-app charging payment launch, but near-term volume uncertainty and analyst downgrades keep a cautious outlook.

Analysis

XPeng’s core issue is timing: technology optionality (vehicle-level AI and software monetization) can re-rate margins substantially, but that value largely accrues only if unit growth and European distribution follow. The next meaningful inflection is the H2 2025 product cycle—if either GX or the new Mona SUV converts at the same attach rates for software and charging services seen in leader models, gross margin expansion could accelerate non-linearly because incremental revenue from services has very high incremental margins.

Second-order beneficiaries are compute and data-infrastructure suppliers rather than traditional auto parts names; scaling VLA-class telematics and OTA fleets pulls demand toward edge/center compute, software tooling, and cybersecurity vendors (higher server spend, recurring cloud services). Conversely, heavy R&D spend and soft early volumes raise the probability of equity-funded dilution within 12 months, which compresses upside for holders absent clear delivery signals.

Key near-term catalysts are independent product reviews, early reservation/ordering data post-launch (6–12 weeks after market launch), and any formal Stellantis commercial partnership terms—each can shift the valuation multiple much faster than sales volumes. Tail risks: product quality/validation setbacks, adverse European homologation requirements, or a need for a near-term capital raise would flip the thesis into a rapid drawdown scenario.

Contrarian take: the market’s discount on XPEV looks driven by near-term unit skepticism while underweighting recurring software/charging revenue potential and a strategic European distribution vector. Positioning should therefore target asymmetric payoffs that cap downside from dilution or execution misses while retaining upside to a successful H2 2025 product reception and a credible Stellantis tie-up.

Key Decisions for Investors

• Buy an XPEV 12-month call spread sized to 1–2% of portfolio notional: long a 12-month call ~25% OTM, sell a 12-month call ~50% OTM (flux strikes to current price). Rationale: captures H2 2025 product re-rate while limiting premium at risk. Risk/reward: premium lost if launches disappoint; payoff 3x–5x if adoption and software monetization accelerate.
• If holding XPEV equity, buy 6–9 month protective puts ~15%–20% OTM sized to cover position. Rationale: hedge against forced dilution or a negative product review in the pre-launch window. Cost: limited to put premium; benefit: caps downside to equity funding/recall tail risks.
• Initiate a 3–12 month long in SMCI (size 1–3% portfolio) to play compute-infrastructure upside from automotive AI scaling. Target +30–40% on 6–12 month horizon if OEMs accelerate on-prem/cloud compute purchases; stop at -15% if macro capex stalls.
• Event conditional: allocate a small tactical long to STLA (or buy STLA 6–12 month calls) only if Stellantis makes a binding equity or distribution commitment to XPeng. Rationale: material partnership reduces GTM risk in Europe and could catalyze a simultaneous re-rating for both names. Risk: if commitment is limited or purely commercial, haircut expected; size accordingly.